James M. Cornelius

This article is a stub. You can help by expanding it.

Biographical Information

"James Cornelius was elected as Mead Johnson Nutrition Board Chairman with its 17 percent partial initial public offering on February 17, 2009. Mr. Cornelius has continued in that role as a non-executive Chairman since Mead Johnson Nutrition’s successful split off from Bristol-Myers Squibb on December 23, 2009. Mr. Cornelius is also currently chairman of the board of directors (non-executive) of Bristol-Myers Squibb, and he has served in such a role since his retirement in May 2010. Previously, he served as chief executive officer of Bristol-Myers Squibb since 2006. Mr. Cornelius served as executive chairman of the board of directors of Guidant Corporation from 1995 until 2006, when he retired from Guidant. He also served as Guidant's chief executive officer from 2005-2006 while the company was being sold to Boston Scientific Corporation for $27 billion. Mr. Cornelius is also a director and chairman of the compensation committe and member of the audit committee of Given Imaging Ltd., an Israeli medical device company listed on the NYSE"